Australia Diagnostic Imaging Equipment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

The australian diagnostic imaging equipment market size is expected to grow from USD 1.03 billion in 2025 to USD 1.1 billion in 2026 and is forecast to reach USD 1.49 billion by 2031 at 6.40% CAGR over 2026-2031. This report is Segmented by Modality (MRI, Computed Tomography (CT), Ultrasound, and More), Portability (Fixed Systems, Mobile and Hand-Held Systems), Application (Cardiology, Oncology, Neurology, and More), End User (Hospitals, Diagnostic Imaging Centres, Other End-Users). The Market Forecasts are Provided in Terms of Value (USD).

Australia Diagnostic Imaging Equipment Market Trends and Insights

Rise in Prevalence of Chronic Diseases

Cardiovascular disease and cancer remain leading death drivers, keeping demand for routine multimodal scans high. Indigenous Australians lose nearly 240,000 healthy life-years annually from illness, prompting targeted imaging subsidies in underserved regions. Vendors now bundle AI triage engines such as GE HealthCare’s CareIntellect to accelerate report delivery for complex oncology pathways. National health data agencies standardize coding to track chronic-disease imaging volumes, supporting predictable equipment upgrades.

Growing Geriatric Population

Australia’s over-65 cohort expands by roughly 3.3% annually, raising incidences of osteoporotic fractures and neurodegenerative disorders that demand age-adapted imaging. Policy frameworks under the National Medical Workforce Strategy address geographic maldistribution that leaves rural elderly communities short of radiology services. Helium-free MRI, such as Siemens MAGNETOM Flow, reduces cryogen dependency while incorporating mood-lighting and noise dampening, addressing comfort concerns for elderly scans. Virtual-care megatrends project remote check-ins with integrated image sharing, shrinking repeat hospital visits for seniors.

Capital Cost of Advanced Modalities

High capital expenditure requirements for next-generation imaging systems create procurement barriers, particularly for smaller healthcare facilities. High-end 3 T MRI or spectral CT can exceed USD 3 million per unit, a threshold that strains district hospitals. Vendor finance packages and leasing are expanding, yet smaller sites still delay upgrades until depreciation schedules end. Australia’s equipment-lifespan rules grant exemptions for early replacement if efficiency gains are proven, encouraging helium-free swaps. Regulatory compliance costs add complexity, with TGA application audit updates focusing on high-risk devices requiring comprehensive documentation for conformity assessments.

Other drivers and restraints analyzed in the detailed report include:

• Increased Adoption of Advanced Imaging Technologies
• Private-Sector Centre Consolidation
• Workforce Shortage of Sonographers

Segment Analysis

Computed tomography posted the quickest 7.65% CAGR, helping the Australian diagnostic imaging equipment market diversify beyond ultrasound leadership. The CT upswing aligns with bedside units, such as Siemens SOMATOM On-site, that bring neuroimaging directly to intensive care beds. Ultrasound remains indispensable across obstetrics, emergency, and primary care pathways due to its portability and cost advantages. MRI growth benefits from helium-free magnet launches that trim life-cycle costs by up to 30%. X-ray systems have shifted toward flat-panel detectors and streamlined workflow guidance, while fluoroscopy platforms incorporate AI-driven dose optimization. Nuclear imaging’s progress hinges on isotope supply; yet, PET-CT retains its niche strength in oncology staging, backed by rebate increases. Mammography manufacturers are incorporating short scan times and AI lesion triage to meet breast-screening mandates. Together, these upgrades sustain a healthy replacement cycle that underpins modality-level revenue growth within the Australian diagnostic imaging equipment market.

The segment’s technology race fosters multi-vendor AI ecosystems, where algorithms from local firms like Harrison.ai can be deployed across hardware from Canon, GE, or Philips. Vendor neutrality helps private imaging chains standardize analytics fleetwide. As reimbursement now rewards quality metrics over raw throughput, software that reduces repeat scans or accelerates diagnosis holds commercial upside. This environment keeps CT and MRI demand resilient, even when capital budgets are tightened. The Australian diagnostic imaging equipment industry, therefore, witnesses continuous innovation in modalities that align clinical outcomes with cost-containment goals.

Fixed rooms still account for 81.44% of revenue, thanks to their comprehensive capabilities; however, mobile and handheld devices are starting to reshape workflows within the Australian diagnostic imaging equipment market. Handheld ultrasound alone recorded more than 2,600 emergency department scans across regional hospitals, achieving a 94% diagnostic utility. Mobile CT and MRI reduce patient transfers, thereby lowering the risk of in-hospital complications. Rural outreach programs leverage truck-mounted magnet units, creating new capital-leasing opportunities for vendors.

The rising adoption of point-of-care services also reflects clinician demand for real-time triage in primary care settings. Artificial intelligence embedded in devices like Philips Lumify automates measurement tasks, which broadens user segments beyond specialist radiologists. Regulatory authorities now provide accelerated routes for low-risk portable devices, shortening the time to market. Collectively, these forces push portability CAGR to 6.88%, reinforcing the decentralization trend that drives incremental equipment sales across the Australian diagnostic imaging equipment market.

Complete Report Scope:

• By Modality
  • MRI
  • Computed Tomography (CT)
  • Ultrasound
  • X-ray
  • Nuclear Imaging (SPECT / PET)
  • Fluoroscopy
  • Mammography
• By Portability
  • Fixed Systems
  • Mobile and Hand-held Systems
• By Application
  • Cardiology
  • Oncology
  • Neurology
  • Orthopedics
  • Gastroenterology
  • Gynecology
  • Other Applications
• By End User
  • Hospitals
  • Diagnostic Imaging Centres
  • Other End-users

List of Companies Covered in this Report:

• Siemens Healthineers
• GE Healthcare
• Koninklijke Philips
• Canon Medical Systems Corp
• Fujifilm Holdings Corp
• Hologic
• Mindray Bio-Medical Electronics
• Carestream Health
• Agfa-Gevaert
• Hitachi Healthcare
• Shimadzu Corp
• Samsung Group
• Esaote
• United Imaging Healthcare
• Telix Pharmaceuticals
• Clarity Pharmaceuticals
• ANSTO
• Lumus Imaging (Healius)
• Integral Diagnostics
• Sonic Healthcare

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support